Skip to main content

Neupro

Generic: rotigotine

Verified·Oct 26, 2026
Manufacturer
UCB
NDC
50474-801
RxCUI
722253
Route
TRANSDERMAL
ICD-10 indication
G20

Affordability Check

How much will you actually pay for Neupro?

In 30 seconds, see every legitimate way to afford Neupro — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Neupro

What is this medication?

Neupro is a prescription medication delivered through a transdermal patch that contains the active ingredient rotigotine. It is classified as a dopamine agonist, which means it works by mimicking the effects of dopamine, a natural substance in the brain that helps regulate movement and coordination. This medication is primarily used to manage the symptoms of Parkinson's disease, including tremors, stiffness, and slow movement, in both early and advanced stages of the condition.

Beyond its application for Parkinson's disease, Neupro is also approved for the treatment of moderate-to-severe primary Restless Legs Syndrome. This condition causes an overwhelming urge to move the legs, typically during the evening or night when a person is resting. The patch is designed to be applied to the skin once every twenty-four hours, providing a continuous and steady release of medicine into the bloodstream. It is important for patients to rotate the application site daily to help prevent skin irritation and ensure the medication remains effective.

Copay & patient assistance

  • Patient Copay Amount: As little as $10 per 30-day supply
  • Maximum Annual Benefit Limit: $1,500 per calendar year
  • Core Eligibility Restrictions: Must be a resident of the United States or Puerto Rico with commercial insurance; not valid for patients covered by federal or state-funded healthcare programs (including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE) or for cash-paying patients.
  • RxBIN, PCN, and Group numbers: RxBIN: 610524; PCN: Not Publicly Available; Group: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Neupro appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

33%

1,839 of 5,499 plans

Most common tier

Tier 4

On 73% of covering formularies

Prior authorization required

3%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)16
15%
Tier 2 (generic)3
3%
Tier 3 (preferred brand)9
9%
Tier 4 (non-preferred brand)76
73%

Step therapy: 8% of formularies

Quantity limits: 26% of formularies

Coverage breadth: 104 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.